News
GLSHQ
0.0001
NaN%
--
Weekly Report: what happened at GLSHQ last week (0406-0410)?
Weekly Report · 2d ago
Weekly Report: what happened at GLSHQ last week (0330-0403)?
Weekly Report · 04/06 10:10
Weekly Report: what happened at GLSHQ last week (0323-0327)?
Weekly Report · 03/30 10:10
Weekly Report: what happened at GLSHQ last week (0316-0320)?
Weekly Report · 03/23 10:06
Weekly Report: what happened at GLSHQ last week (0309-0313)?
Weekly Report · 03/16 10:06
Weekly Report: what happened at GLSHQ last week (0302-0306)?
Weekly Report · 03/09 10:07
Weekly Report: what happened at GLSHQ last week (0223-0227)?
Weekly Report · 03/02 10:06
Weekly Report: what happened at GLSHQ last week (0216-0220)?
Weekly Report · 02/23 10:06
Weekly Report: what happened at GLSHQ last week (0209-0213)?
Weekly Report · 02/16 10:06
Weekly Report: what happened at GLSHQ last week (0202-0206)?
Weekly Report · 02/09 10:07
Weekly Report: what happened at GLSHQ last week (0126-0130)?
Weekly Report · 02/02 10:07
Weekly Report: what happened at GLSHQ last week (0119-0123)?
Weekly Report · 01/26 10:06
Weekly Report: what happened at GLSHQ last week (0112-0116)?
Weekly Report · 01/19 10:12
Weekly Report: what happened at GLSHQ last week (0105-0109)?
Weekly Report · 01/12 10:11
Weekly Report: what happened at GLSHQ last week (1229-0102)?
Weekly Report · 01/05 10:06
Weekly Report: what happened at GLSHQ last week (1222-1226)?
Weekly Report · 12/29/2025 10:05
Weekly Report: what happened at GLSHQ last week (1215-1219)?
Weekly Report · 12/22/2025 10:05
Weekly Report: what happened at GLSHQ last week (1208-1212)?
Weekly Report · 12/15/2025 10:11
Weekly Report: what happened at GLSHQ last week (1201-1205)?
Weekly Report · 12/08/2025 10:10
Weekly Report: what happened at GLSHQ last week (1124-1128)?
Weekly Report · 12/01/2025 10:06
More
Webull provides a variety of real-time GLSHQ stock news. You can receive the latest news about Gelesis Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GLSHQ
Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).